Erudio Healtherudio.com
Drug
Prednisolone trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying prednisolone: CYCLONE 3. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 8 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| CYCLONE 3 NCT05288166 · Eli Lilly and Company | high-risk metastatic hormone-sensitive prostate cancer | Phase 3 | 218 | 14 | Standard | Nov 17, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| AALL1731 NCT03914625 · National Cancer Institute (NCI) DeepView → | newly diagnosed standard-risk B-cell acute lymphoblastic leukemia | Phase 3 | Deep | View | |||
| AHOD2131 NCT05675410 · National Cancer Institute (NCI) DeepView → | newly diagnosed stage I/II classic Hodgkin lymphoma | Phase 3 | Deep | View | |||
| KEYLYNK-010 NCT03834519 · Merck Sharp & Dohme LLC DeepView → | previously treated biomarker-unselected metastatic castration-resistant prostate cancer | Phase 3 | Deep | View | |||
| STAMPEDE NCT00268476 · Medical Research Council StandardView → | advanced or metastatic prostate cancer | Phase 2/Phase 3 | Standard | View | |||
| AALL1732 NCT03959085 · Children's Oncology Group FocusedView → | high-risk B-ALL, mixed phenotype acute leukemia, B-LLy | Phase 3 | Focused | View | |||
| E7438-G000-101 NCT01897571 · Epizyme, Inc. FocusedView → | B-cell lymphomas and advanced solid tumors | Phase 1/Phase 2 | Focused | View | |||
| STELLAR NCT03899337 · University of Birmingham FocusedView → | Richter's syndrome | Phase 2 | Focused | View | |||
| AALL2131 NCT06124157 · National Cancer Institute (NCI) FocusedView → | Ph+ or ABL-class Ph-like B-cell acute lymphoblastic leukemia | Phase 2 | Focused | View | |||